← Back to headlines

FDA approves leucovorin for ultrarare cerebral folate deficiency subset without clinical trial

This story is reported by Fierce Pharma. Read what other outlets are saying below, then open the original report for full details.

FDA approves leucovorin for ultrarare cerebral folate deficiency subset without clinical trial · NabkaNews